poisar

Stocks · News reference

ENvue Medical Completes Move Of NanoVibronix Manufacturing From Israel To The U.S. And Consolidates R&D Operations In Tel Aviv To Lower Opex And Improve Cost Structure

Aug 4, 2026, 1:04 PMBenzinga Newsdesk

By completing this transition, the Company now manufactures its entire NanoVibronix line in the United States, leveraging these U.S.-based operations to establish a stronger foundation for long-term growth and strategic

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

FEED
Source
benzinga
Observed
Aug 4, 2026, 1:04 PM
Checked
Aug 4, 2026, 1:04 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading